ADESSO SE (ADN1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ADN1 - DE000A0Z23Q5 - Common Stock
91.4 EUR
+2 (+2.24%)
Overall ADN1 gets a fundamental rating of 5 out of 10. We evaluated ADN1 against 76 industry peers in the IT Services industry. ADN1 has an average financial health and profitability rating. ADN1 is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
ADN1 had positive earnings in the past year.
ADN1 had a positive operating cash flow in the past year.
Each year in the past 5 years ADN1 has been profitable.
ADN1 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ADN1 has a Return On Assets of 2.45%. This is in the lower half of the industry: ADN1 underperforms 63.16% of its industry peers.
Looking at the Return On Equity, with a value of 10.90%, ADN1 is in line with its industry, outperforming 48.68% of the companies in the same industry.
With a Return On Invested Capital value of 5.23%, ADN1 is not doing good in the industry: 64.47% of the companies in the same industry are doing better.
ADN1 had an Average Return On Invested Capital over the past 3 years of 3.16%. This is significantly below the industry average of 25.87%.
The last Return On Invested Capital (5.23%) for ADN1 is above the 3 year average (3.16%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROIC | 5.23% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
1.3 Margins
The Profit Margin of ADN1 (0.99%) is worse than 67.11% of its industry peers.
ADN1's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.96%, ADN1 is doing worse than 67.11% of the companies in the same industry.
ADN1's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 85.30%, ADN1 is doing good in the industry, outperforming 77.63% of the companies in the same industry.
ADN1's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% |
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN1 is destroying value.
Compared to 1 year ago, ADN1 has less shares outstanding
ADN1 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ADN1 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.64 indicates that ADN1 is not in any danger for bankruptcy at the moment.
ADN1 has a Altman-Z score of 3.64. This is in the better half of the industry: ADN1 outperforms 75.00% of its industry peers.
ADN1 has a debt to FCF ratio of 7.88. This is a slightly negative value and a sign of low solvency as ADN1 would need 7.88 years to pay back of all of its debts.
The Debt to FCF ratio of ADN1 (7.88) is worse than 65.79% of its industry peers.
A Debt/Equity ratio of 1.60 is on the high side and indicates that ADN1 has dependencies on debt financing.
The Debt to Equity ratio of ADN1 (1.60) is worse than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Altman-Z | 3.64 |
ROIC/WACC0.94
WACC5.59%
2.3 Liquidity
A Current Ratio of 1.30 indicates that ADN1 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.30, ADN1 perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
A Quick Ratio of 1.30 indicates that ADN1 should not have too much problems paying its short term obligations.
ADN1's Quick ratio of 1.30 is fine compared to the rest of the industry. ADN1 outperforms 60.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 200.98% over the past year.
The earnings per share for ADN1 have been decreasing by -15.02% on average. This is quite bad
ADN1 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.60%.
ADN1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.60% yearly.
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
3.2 Future
ADN1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.34% yearly.
The Revenue is expected to grow by 10.28% on average over the next years. This is quite good.
EPS Next Y83.56%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
EPS Next 5Y39.34%
Revenue Next Year10.53%
Revenue Next 2Y10.3%
Revenue Next 3Y10.23%
Revenue Next 5Y10.28%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 28.65, which means the current valuation is very expensive for ADN1.
Compared to the rest of the industry, the Price/Earnings ratio of ADN1 is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.19. ADN1 is around the same levels.
A Price/Forward Earnings ratio of 16.16 indicates a correct valuation of ADN1.
ADN1's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.92, ADN1 is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.65 | ||
| Fwd PE | 16.16 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ADN1 is valued a bit cheaper than the industry average as 71.05% of the companies are valued more expensively.
ADN1's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ADN1 is cheaper than 67.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.77 | ||
| EV/EBITDA | 6.74 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ADN1's earnings are expected to grow with 63.28% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y76.08%
EPS Next 3Y63.28%
5. Dividend
5.1 Amount
ADN1 has a yearly dividend return of 0.84%, which is pretty low.
ADN1's Dividend Yield is comparable with the industry average which is at 2.26.
Compared to an average S&P500 Dividend Yield of 1.92, ADN1's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.84% |
5.2 History
On average, the dividend of ADN1 grows each year by 15.65%, which is quite nice.
Dividend Growth(5Y)15.65%
Div Incr Years5
Div Non Decr Years6
5.3 Sustainability
31.75% of the earnings are spent on dividend by ADN1. This is a low number and sustainable payout ratio.
The dividend of ADN1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.75%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
FRA:ADN1 (1/9/2026, 7:00:00 PM)
91.4
+2 (+2.24%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners20.34%
Inst Owner ChangeN/A
Ins Owners50.28%
Ins Owner ChangeN/A
Market Cap596.84M
Revenue(TTM)2.10B
Net Income(TTM)20.84M
Analysts83.33
Price Target126.63 (38.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.84% |
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP31.75%
Div Incr Years5
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.91%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.65 | ||
| Fwd PE | 16.16 | ||
| P/S | 0.28 | ||
| P/FCF | 12.77 | ||
| P/OCF | 7.68 | ||
| P/B | 3.12 | ||
| P/tB | 11.79 | ||
| EV/EBITDA | 6.74 |
EPS(TTM)3.19
EY3.49%
EPS(NY)5.65
Fwd EY6.19%
FCF(TTM)7.16
FCFY7.83%
OCF(TTM)11.9
OCFY13.02%
SpS322.11
BVpS29.27
TBVpS7.75
PEG (NY)0.34
PEG (5Y)N/A
Graham Number45.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROCE | 11.91% | ||
| ROIC | 5.23% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 8.22% | ||
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% | ||
| FCFM | 2.22% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexgc growth 3Y-20.34%
ROICexgc growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score7
Asset Turnover2.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Debt/EBITDA | 2.26 | ||
| Cap/Depr | 42.37% | ||
| Cap/Sales | 1.47% | ||
| Interest Coverage | 5.03 | ||
| Cash Conversion | 57.42% | ||
| Profit Quality | 224.33% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 3.64 |
F-Score7
WACC5.59%
ROIC/WACC0.94
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
EPS Next Y83.56%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
EPS Next 5Y39.34%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
Revenue Next Year10.53%
Revenue Next 2Y10.3%
Revenue Next 3Y10.23%
Revenue Next 5Y10.28%
EBIT growth 1Y38.36%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year304.77%
EBIT Next 3Y78.82%
EBIT Next 5Y44.13%
FCF growth 1Y300.77%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y1010.67%
OCF growth 3Y32.14%
OCF growth 5Y37.69%
ADESSO SE / ADN1.DE FAQ
What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.
Can you provide the valuation status for ADESSO SE?
ChartMill assigns a valuation rating of 5 / 10 to ADESSO SE (ADN1.DE). This can be considered as Fairly Valued.
What is the profitability of ADN1 stock?
ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ADESSO SE (ADN1.DE) stock?
The Price/Earnings (PE) ratio for ADESSO SE (ADN1.DE) is 28.65 and the Price/Book (PB) ratio is 3.12.
Can you provide the expected EPS growth for ADN1 stock?
The Earnings per Share (EPS) of ADESSO SE (ADN1.DE) is expected to grow by 83.56% in the next year.